Somatostatin Receptor
Somatostatin receptor is a G protein-coupled receptor that includes five known somatostatin receptors.
Products Related to Somatostatin Receptor(43)
- GC10181L-803,087 trifluoroacetateCAS: 217480-26-7Purity: >96.00%
L-803,087 trifluoroacetate is a potent and selective somatostatin sst4 receptor agonist with a Ki of 0.7 nM.
- GC12835Cortistatin 14CAS: 193829-96-8Purity: >99.50%
Cortistatin 14 (CST-14, human, rat), a neuropeptide with neuronal depressant and sleep modulating properties, can bind to all five cloned somatostatin receptors (SSTRs) and ghrelin receptor to exert its biological activities and co-exists with GABA within the cortex and hippocampus.
- GC14747CYN 154806CAS: 183658-72-2Purity: >98%
CYN 154806 is a cyclic octapeptide and a potent, selective somatostatin sst2 receptor antagonist (pIC₅₀=8.58). CYN 154806 also inhibits sst1, sst3, sst4, and sst5 receptors.
- GC16919(1R,1'S,3'R/1R,1'R,3'S)-L-054,264CAS: 208706-12-1Purity: >98%
somatostatin sst2 receptor agonist
- GC34130Vapreotide acetate (RC-160 acetate)CAS: 849479-74-9Purity: >99.50%
Vapreotide acetate (RC-160 acetate) (RC-160 acetate; BMY-41606 acetate) is a neurokinin-1 (NK1) receptor antagonist, with an IC50 of 330 nM.
- GC35730Cortistatin-14 TFACAS: 186901-48-4Purity: >98.00%
Cortistatin-14 TFA, a neuropeptide, is present primarily in the cortex and hippocampus, which inhibits neuronal firing of hippocampal CA1 neurons.
- GC35787CYN 154806 TFACAS: 2828432-46-6Purity: >98%
CYN 154806 TFA, a cyclic octapeptide, is a potent and selective somatostatin sst2 receptor antagonist, with pIC50 values of 8.58, 5.41, 6.07, 5.76 and 6.48 for human recombinant sst2, sst1, sst3, sst4 and sst5 receptors respectively.
- GC36857Pasireotide ditrifluoroacetatePurity: >99.00%
Pasireotide (SOM230) ditrifluoroacetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively).
- GC36858Pasireotide L-aspartate saltCAS: 396091-77-3Purity: >99.00%
Pasireotide (SOM230) L-aspartate salt, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively).
- GC61413J-2156 TFACAS: 2387505-73-7Purity: >99.50%
J-2156 TFA is a high potent, selective somatostatin receptor type 4 (SST4 receptor) agonist with IC50s of 0.05 nM and 0.07 nM for human and rat SST4 receptors, respectively.
- GC62194Pasireotide acetateCAS: 396091-76-2Purity: >99.50%
Pasireotide (SOM230) acetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10181 | L-803,087 trifluoroacetate | 217480-26-7 | >96.00% | |
L-803,087 trifluoroacetate is a potent and selective somatostatin sst4 receptor agonist with a Ki of 0.7 nM. | ||||
| GC10328 | TT 232 | 147159-51-1 | >98% | |
sst1/sst4 somatostatin receptors agonist | ||||
| GC10899 | Octreotide acetate | 83150-76-9 | >99.50% | |
A somatostatin receptor agonist | ||||
| GC12448 | NNC 26-9100 | 199522-35-5 | >98% | |
Somatostatin sst4 receptor agonist | ||||
| GC12835 | Cortistatin 14 | 193829-96-8 | >99.50% | |
Cortistatin 14 (CST-14, human, rat), a neuropeptide with neuronal depressant and sleep modulating properties, can bind to all five cloned somatostatin receptors (SSTRs) and ghrelin receptor to exert its biological activities and co-exists with GABA within the cortex and hippocampus. | ||||
| GC13686 | CH 275 | 174688-78-9 | >98% | |
Potent somatostatin receptor 1 (sst1) agonist | ||||
| GC13758 | Seglitide | 81377-02-8 | >98% | |
sst2 and sst5 somatostatin receptors agonist | ||||
| GC14119 | BIM 23052 | 133073-82-2 | >98% | |
sst5 receptor agonist | ||||
| GC14747 | CYN 154806 | 183658-72-2 | >98% | |
CYN 154806 is a cyclic octapeptide and a potent, selective somatostatin sst2 receptor antagonist (pIC₅₀=8.58). CYN 154806 also inhibits sst1, sst3, sst4, and sst5 receptors. | ||||
| GC15495 | Cyclosomatostatin | 84211-54-1 | >98% | |
somatostatin receptor antagonist | ||||
| GC16400 | BIM 23056 | 150155-61-6 | >99.50% | |
Somatostatin receptor ligand | ||||
| GC16422 | Somatostatin 1-28 | 74315-46-1 | >98% | |
Somatostatin receptor agonist | ||||
| GC16919 | (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 | 208706-12-1 | >98% | |
somatostatin sst2 receptor agonist | ||||
| GC17668 | L-817,818 | 217480-27-8 | >98% | |
somatostatin sst5 receptor agonist | ||||
| GC31349 | MK-4256 | 1104599-69-0 | >99.00% | |
MK-4256 is a potent and selective SSTR3 antagonist with IC50s of 0.66 nM and 0.36 nM in human and mouse receptor binding assays, respectively. | ||||
| GC34130 | Vapreotide acetate (RC-160 acetate) | 849479-74-9 | >99.50% | |
Vapreotide acetate (RC-160 acetate) (RC-160 acetate; BMY-41606 acetate) is a neurokinin-1 (NK1) receptor antagonist, with an IC50 of 330 nM. | ||||
| GC35730 | Cortistatin-14 TFA | 186901-48-4 | >98.00% | |
Cortistatin-14 TFA, a neuropeptide, is present primarily in the cortex and hippocampus, which inhibits neuronal firing of hippocampal CA1 neurons. | ||||
| GC35787 | CYN 154806 TFA | 2828432-46-6 | >98% | |
CYN 154806 TFA, a cyclic octapeptide, is a potent and selective somatostatin sst2 receptor antagonist, with pIC50 values of 8.58, 5.41, 6.07, 5.76 and 6.48 for human recombinant sst2, sst1, sst3, sst4 and sst5 receptors respectively. | ||||
| GC36358 | J-2156 | 848647-56-3 | >98% | |
J-2156 is a high potent, selective somatostatin receptor type 4 (SST4 receptor) agonist with IC50s of 0.05 nM and 0.07 nM for human and rat SST4 receptors, respectively. | ||||
| GC36857 | Pasireotide ditrifluoroacetate | - | >99.00% | |
Pasireotide (SOM230) ditrifluoroacetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). | ||||
| GC36858 | Pasireotide L-aspartate salt | 396091-77-3 | >99.00% | |
Pasireotide (SOM230) L-aspartate salt, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). | ||||
| GC50094 | TC-G 1003 | 1021912-42-4 | >98% | |
TC-G 1003 is a potent somatostatin receptor subtype 2 (sst2) agonist with a Ki value of 0.025 nM and a cAMP IC50 value of 4.8 nM. | ||||
| GC61413 | J-2156 TFA | 2387505-73-7 | >99.50% | |
J-2156 TFA is a high potent, selective somatostatin receptor type 4 (SST4 receptor) agonist with IC50s of 0.05 nM and 0.07 nM for human and rat SST4 receptors, respectively. | ||||
| GC62194 | Pasireotide acetate | 396091-76-2 | >99.50% | |
Pasireotide (SOM230) acetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). | ||||
